|
|
Article: Allergan Releases Top-Line Results from Phase III Botox Headache Program.
- Article from:
- Health & Beauty Close-Up
- Article date:
- September 16, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEALTH AND BEAUTY CLOSE-UP-16 September 2008-Allergan Releases Top-Line Results from Phase III Botox Headache Program(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com
Allergan announced that it has completed a top-line analysis of its two Phase III clinical trials exploring the use of Botox (botulinum toxin type A) for the prophylactic treatment of headache in adults suffering from chronic migraine - i.e., headaches and/or migraines that occur on 15 or more days each month.
In a release, the company noted:
Botox is the first therapy being investigated for this extremely debilitating condition of chronic migraine, which is estimated to affect ...